What should you know about early morphea?

Morphea, also called localised scleroderma, causes inflammation and increased firmness in areas of skin. An early patch may look pink, red, purple, or lighter than the surrounding skin before developing a smooth, shiny, or hardened centre. The border can appear more active than the middle. It may itch, feel tight, or be sensitive, although some patches cause little discomfort. Morphea is not the same as systemic scleroderma, but location, depth, and speed of change matter; patches near a joint, on the face, or over the scalp deserve careful assessment.

Arrange a dermatology examination for a new patch that is enlarging, hardening, changing colour, or restricting movement. The clinician may compare photographs, examine the skin and joints, and sometimes recommend a biopsy. Keep the area moisturised, protect it from sun exposure, and avoid aggressive scrubbing or unplanned steroid use. Treatment depends on depth and activity. Topical Calcineurin Inhibitors may be considered for selected superficial areas, while Narrowband UVB Phototherapy can be discussed when a dermatologist believes light treatment fits the pattern.

Seek prompt review if a patch expands quickly, becomes painful, ulcerates, crosses a joint, or causes reduced movement. Facial or scalp lesions, changes near the eye, or a tight band around a limb should not be ignored because deeper involvement can affect nearby structures. Contact your clinician sooner if new patches appear while you are awaiting assessment. Early review helps distinguish morphea from other causes of firm or discoloured skin and supports timely treatment.

Does the patch look active or deep, and would a biopsy help? Could it affect a joint, the face, or the scalp? Which treatment is suitable for its location, and how will we monitor colour, firmness, and movement?